Consumer advocacy organization pushes back on Health Canada’s proposal to restrict vape flavours

Events
May.31.2022
“Flavour restrictions either work or they do not when it comes to preventing youth use. You cannot say they’re needed for nicotine vaping but not alcohol and cannabis.”

The poll was conducted online by Delphi Polling & Consulting between Apr. 29 and May 10, through a demographically representative sample of 1,200 Canadians of legal vaping age in their respective province. The survey was available in English and French and used interlocking quotas with targets set out in the most recent Census around age, gender, province and language (for Quebec).

 

The organization adds that banning most flavoured vaping products could push some consumers back to smoking, ultimately creating worse health outcomes. They also argue that if flavour restrictions are placed on nicotine products, similar restrictions should be placed on cannabis and alcohol products.

 

“Flavour restrictions either work or they do not when it comes to preventing youth use. You cannot say they’re needed for nicotine vaping, but not alcohol and cannabis. As an organization that defends consumer choice, we are opposed to prohibitions generally and would like to see more sophisticated policy-making from Health Canada,” Cran said.

 

The proposed amendments to the Tobacco and Vaping Products Act (Flavours)would restrict the promotion of flavours to tobacco or mint/menthol. The use of all sugars and sweeteners as well as flavouring ingredients, with limited exceptions, would also be prohibited in the manufacture of vaping products.

 

Health Canada notes that Canadians had the opportunity to provide commentson the regulatory proposal during the Canada Gazette, Part I, public comment period, which started on June 19, 2021 and lasted 75 days.

 

source:The GrowthOp

The organization argues that banning most flavoured vaping products could push some consumers back to smoking, ultimately creating worse health outcomes. /

 

FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
The U.S. Food and Drug Administration issued guidance on May 8, 2026, titled “Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization.” The document describes FDA enforcement policies for certain electronic nicotine delivery system products and nicotine pouch products marketed without premarket authorization.
May.09 by 2FIRSTS.ai
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Product | ZYN Adds Tropical Flavor and Expands 1.5mg Nicotine Options in the Philippines
Product | ZYN Adds Tropical Flavor and Expands 1.5mg Nicotine Options in the Philippines
ZYN has expanded its nicotine pouch portfolio in the Philippines with the addition of Cool Breeze 1.5mg and Tropical in 3mg and 6mg strengths. Public information shows that 1.5mg is among the lower nicotine strengths offered by ZYN in the Philippine market and is positioned for adult nicotine consumers who are new to nicotine pouches.
PMI
Jun.08
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
ITGA Americas Meeting Calls for Balanced Regulation as Tobacco Growers Warn of Pressure on Farms and Legal Supply Chains
ITGA Americas Meeting Calls for Balanced Regulation as Tobacco Growers Warn of Pressure on Farms and Legal Supply Chains
ITGA said tobacco grower organizations from five Americas countries called for stronger regional cooperation and balanced regulation, warning that restrictive policies could pressure farmers and legal supply chains. The article also provides data on major tobacco-producing countries in the Americas.
Special Report
Jun.02